...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM Voting
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I'll take $2 US vs handing the company off to someone who will wipe out current shareholders.

I'll take $2 US vs sitting here for another 5 or 10 years.

But hey, pick whatever "fair value" number works for you and I'm sure I'll be fine with it.

 

 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply